Clinical trial of blood-brain barrier disruption by pulsed ultrasound

Science Translational Medicine

Volumn 8, Issue 343, 2016, Pages

  Carpentier, Alexandre ^a,b   Canney, Michael ^c   Vignot, Alexandre ^c   Reina, Vincent ^a,b   Beccaria, Kevin ^a   Horodyckid, Catherine ^a   Karachi, Carine ^a,b   Leclercq, Delphine ^a   Lafon, Cyril ^d   Chapelon, Jean Yves ^d   Capelle, Laurent ^a   Cornu, Philippe ^a,b   Sanson, Marc ^a,b,e,f,g   Hoang Xuan, Khê ^a,b,e,f,g   Delattre, Jean Yves ^a,b,e,f,g   Idbaih, Ahmed ^a,b,e,f,g  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^d LABTAU   (France)

^e INSERM   (France)

^f CNRS   (France)

^g ICM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD BRAIN BARRIER; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG HALF LIFE; FEMALE; GLIOBLASTOMA; HUMAN; MALE; MICROBUBBLE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRECLINICAL STUDY; PRIORITY JOURNAL; ULTRASOUND SURGERY; ULTRASOUND TRANSDUCER; BRAIN; CLINICAL TRIAL; DRUG EFFECTS; RADIATION RESPONSE; ULTRASOUND;

BLOOD-BRAIN BARRIER; BRAIN; CARBOPLATIN; FEMALE; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICROBUBBLES; ULTRASONIC WAVES;

EID: 84975090470     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aaf6086     Document Type: Article

References (35)

1. M. O. Jacus, V. M. Daryani, K. E. Harstead, Y. T. Patel, S. L. Throm, C. F. Stewart, Pharmacokinetic properties of anticancer agents for the treatment of central nervous system tumors: Update of the literature. Clin. Pharmacokinet. 55, 297-311 (2016).
2. B. Vastag, Biotechnology: Crossing the barrier. Nature 466, 916-918 (2010).
3. A. Dove, Breaching the Barrier. Nat. Biotech. 26, 1213-1215 (2008).
4. S. S. Gill, N. K. Patel, G. R. Hotton, K. O'Sullivan, R. McCarter, M. Bunnage, D. J. Brooks, C. N. Svendsen, P. Heywood, Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat. Med. 9, 589-595 (2003).
5. L. H. Treat, N. McDannold, Y. Zhang, N. Vykhodtseva, K. Hynyen, Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma. Ultrasound Med. Biol. 38, 1716-1725 (2012).
6. H.-L. Liu, M.-Y. Hua, P.-Y. Chen, P.-C. Chu, C.-H. Pan, H.-W. Yang, C.-Y. Huang, J.-J. Wang, T.-C. Yen, K.-C. Wei, Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. Radiology 255, 415-425 (2010).
7. K. Beccaria, M. Canney, L. Goldwirt, C. Fernandez, J. Piquet, M.-C. Perier, C. Lafon, J.-Y. Chapelon, A. Carpentier, Ultrasound-induced opening of the blood-brain barrier to enhance temozolomide and irinotecan delivery: An experimental study in rabbits. J. Neurosurg. 10.3171/2015.4.JNS142893 (2015).
8. K. Beccaria, M. Canney, L. Goldwirt, C. Fernandez, C. Adam, J. Piquet, G. Autret, O. Clément, C. Lafon, J.-Y. Chapelon, A. Carpentier, Opening of the blood-brain barrier with an unfocused ultrasound device in rabbits. J. Neurosurg. 119, 887-898 (2013).
9. K.-C. Wei, P.-C. Chu, H.-Y. J. Wang, C.-Y. Huang, P.-Y. Chen, H.-C. Tsai, Y.-J. Lu, P.-Y. Lee, I.-C. Tseng, L.-Y. Feng, P.-W. Hsu, T.-C. Yen, H.-L. Liu, Focused ultrasound-induced blood-brain barrier opening to enhance Temozolomide delivery for glioblastoma treatment: A preclinical study. PLOS One 8, e58995 (2013).
10. E.-J. Park, Y.-Z. Zhang, N. Vykhodtseva, N. McDannold, Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model. J. Control. Release 163, 277-284 (2012).
11. N. McDannold, N. Vykhodtseva, K. Hynyen, Blood-brain barrier disruption induced by focused ultrasound and circulating preformed microbubbles appears to be characterized by the mechanical index. Ultrasound Med. Biol. 34, 834-840 (2008).
12. C. Horodyckid, M. Canney, A. Vignot, R. Boisgard, A. Drier, G. Huberfeld, C. Francois, A. Prigent, M. Santin, C. Adam, J.-C. Willer, C. Lafon, J.-Y. Chapelon, A. Carpentier, Safe long-term repeated disruption of the blood-brain barrier using an implantable ultrasound device: A multiparametric study in primates. J. Neurosurg., 10.3171/2016.3.JNS151635 (2016).
13. K. Hynynen, N. McDannold, N. Vykhodtseva, F. Jolesz, Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 220, 640-646 (2001).
14. L. Goldwirt, M. Canney, C. Horodyckid, J. Poupon, S. Mourah, A. Vignot, J.-Y. Chapelon, A. Carpentier, Enhanced brain distribution of carboplatin in a primate model after blood-brain barrier disruption using an implantable ultrasound device. Cancer Chemother. Pharmacol. 77, 211-216 (2016).
15. N. McDannold, C. Arvanitis, N. Vykhodtseva, M. Livingstone, Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: Safety and efficacy evaluation in rhesus macaques. Cancer Res. 72, 3652-3663 (2012).
16. S. Monteith, J. Sheehan, R. Medel, M. Wintermark, M. Eames, J. Snell, N. F. Kassell, W. J. Elias, Potential incracranial applications of magnetic resonance-guided focused ultrasound surgery. J. Neurosurg. 118, 215-221 (2013).
17. W. K. Yung, L. Mechtler, M. J. Gleason, Intravenous carboplatin for recurrent malignant glioma: A phase II study. J. Clin. Oncol. 9, 860-864 (1991).
18. H. I. Robins, S. M. Chang, M. D. Prados, W. K. A. Yung, K. Hess, D. Schiff, H. Greenberg, K. Fink, K. Nicolas, J. G. Kuhn, T. Cloughesy, L. Junck, M. Mehta, A phase II trial of thymidine and carboplatin for recurrent malignant glioma: A North American Brain Tumor Consortium Study. Neuro Oncol. 4, 109-114 (2002).
19. E. White, A. Bienemann, H. Taylor, K. Hopkins, A. Cameron, S. Gill, A phase I trial of carboplatin administered by convection-enhanced delivery to patients with recurrent/progressive glioblastoma multiforme. Contemp. Clin. Trials 33, 320-331 (2012).
20. J. Y. Follézou, F. Fauchon, J. Chiras, Intraarterial infusion of carboplatin in the treatment of malignant gliomas: A phase II study. Neoplasma 36, 349-352 (1989).
21. J. E. Wolff, T. Trilling, G. Molenkamp, R. M. Egeler, H. Jurgens, Chemosensitivity of glioma cells in vitro: A meta-analysis. J. Cancer Res. Clin. Oncol. 125, 481-486 (1999).
22. M. A. O'Reilly, Y. Huang, K. Hynynen, The impact of standing wave effects on transcranial focused ultrasound disruption of the blood-brain barrier in a rat model. Phys. Med. Biol. 55, 5251-5267 (2010).
23. N. McDannold, Y. Zhang, N. Vykhodtseva, Blood-brain barrier disruption and vascular damage induced by ultrasound bursts combined with microbubbles can be influenced by choice of anesthesia protocol. Ultrasound Med. Biol. 37, 1259-1270 (2011).
24. G. Leinega, J. Götz, Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer's disease mouse model. Sci. Transl. Med. 7, 278ra33 (2015).
25. J. Park, Y. Zhang, N. Vykhodtseva, F. Jolesz, N. McDannold, The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound. J. Control. Release 162, 134-142 (2012).
26. O. Cohen-Inbar, Z. Xu, J. P. Sheehan, Focused ultrasound-aided immunomodulation in glioblastoma multiforme: A therapeutic concept. J. Ther. Ultrasound 4, 2 (2016).
27. P.-Y. Chen, H.-Y. Hsieh, C.-Y. Huang, C.-Y. Lin, K.-C. Wei, H.-L. Liu, Focused ultrasound-induced blood-brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: A preclinical feasibility study. J. Transl. Med. 13, 93 (2015).
28. R. Alkins, A. Burgess, M. Ganguly, G. Francia, R. Kerbel, W. S. Wels, K. Hynynen, Focused ultrasound delivers targeted immune cells to metastatic brain tumors. Cancer Res. 73, 1892-1899 (2013).
29. J. F. Jordão, E. Thévenot, K. Marham-Coultes, T. Scarcelli, Y.-Q. Weng, K. Xhima, M. O'Reilly, Y. Huang, J. McLaurin, K. Hynynen, I. Aubert, Amyloid-β plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound. Exp. Neurol. 248, 16-29 (2013).
30. T. Scarecelli, J. F. Jordão, M. A. O'Reilly, N. Ellens, K. Hynynen, I. Aubert, Stimulation of hippocampal neurogenesis by transcranial focused ultrasound and microbubbles in adult mice. Brain Stimul. 7, 304-307 (2014).
31. R. Simon, L. Rubinstein, S. G. Arbuck, M. C. Christian, Accelerated titration designs for phase I clinical trials in oncology. J. Natl. Cancer Inst. 89, 1138-1147 (1997).
32. P. Y. Wen, D. R. Macdonald, D. A. Reardon, T. F. Cloughesy, A. G. Sorensen, E. Galanis, J. DeGroot, W. Wick, M. R. Gilbert, A. B. Lassman, C. Tsien, T. Mikkelsen, E. T. Wong, M. C. Chamberlain, R. Stupp, K. R. Lamborn, M. A. Vogelbaum, M. J. van den Bent, S. M. Chang, Updated response assessment criteria for high-grade gliomas: Response assessment in neuro-oncology working group. J. Clin. Oncol. 28, 1963-1972 (2010).
33. R. J. McGough, T. V. Samulski, J. Kelly, An efficient grid sectoring method for calculations of the near-field pressure generated by a circular piston. J. Acoust. Soc. Am. 115, 1942-1954 (2004).
34. A. H. Calvert, D. R. Newell, L. A. Gumbrell, S. O'Reilly, M. Burnell, F. E. Boxall, Z. H. Siddik, I. R. Judson, M. E. Gore, E. Wiltshaw, Carboplatin dosage: Prospective evaluation of a simple formula based on renal function. J. Clin. Oncol. 7, 1748-1756 (1989).
35. S. B. Duffull, B. A. Robinson, Clinical pharmacokinetics and dose optimisation of carboplatin. Clin. Pharmacokinet. 33, 161-183 (1997).